Access the Endocrinology Newsmakers Dashboard (Free Excel) Lillys Mounjaro, Novos Wegovy gear up for larger share of obesity pie In May 2022, Lillys potential blockbuster Mounjaro (tirzepatide) was approved by the US Food and Drug Administration (FDA) as a once-weekly subcutaneous injection to treat adults with type 2 diabetes
Lifestyle Factors For optimal outcomes, consider combining with supportive habits: Maintain adequate protein intake (1.62.2 g/kg body weight)
However, it is still important to approach the topic carefully
For instance, identifying loss-of-function mutations in the IL-36Ra gene has led to developing IL-36 inhibitors for patients with GPP (Johnston et al
Feeding lactobacilli impacts lupus progression in (Nzbxnzw)F1 lupus-prone mice by enhancing immunoregulation
Baseline inflammatory markers (CRP, ESR, IL-6 if available), imaging of known endometriotic lesions, a bone density scan if you have had prior GnRH agonist use, and metabolic parameters provide objective data to track whether the medication is producing measurable changes
